Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2026.189680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Kaitong Mai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Taikang Tongji Wuhan Hospital, Hubei Key Laboratory of Hepato-Pancr…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lipid Metabolism. Die Arbeit nennt 199 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Huazhong University of Science and Technology.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) remains a major global malignancy with high incidence and poor survival rates. Etiology-driven metabolic-immune interactions have emerged as a unifying framework for deciphering hepatocarcinogenesis. Hepatitis B virus (HBV) and metabolic dysfunction-associated steatotic liver disease (MASLD) are the two predominant etiological drivers for HCC. Although immunotherapy serves as a cornerstone of HCC treatment, therapeutic response varies considerably across distinct etiologies. Accumulating evidence suggests that etiology-specific dysregulation of lipid metabolism shapes immune imbalance in the tumor microenvironment, thereby accounting for the heterogeneous responses to immunotherapy. Therefore, deciphering etiology-driven metabolic-immune crosstalk may provide new opportunities to improve therapeutic responses. In this review, we propose the framework of etiology-driven metabolic-immune interactions by comparing two major etiologies, HBV and MASLD. Moreover, taking into account the crucial role of lipid metabolism in hepatocarcinogenesis, dietary interventions and lipid metabolism-targeted therapies have also been included so as to offer potential therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Taikang Tongji Wuhan Hospital, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huaz…
- Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Clinical Medicine Research Center for Hepatic Su…
Förderung
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
Zitieren
APA
Mai, K., Jiang, J., Ma, X., Huang, W., & Xia, L. (2026). Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189680
Vancouver
Mai K, Jiang J, Ma X, Huang W, Xia L. Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189680
BibTeX
@article{Mai2026,
author = {Mai, Kaitong and Jiang, Junqing and Ma, Xianglong and Huang, Wenjie and Xia, Limin},
title = {Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2026.189680}
}
EUVIMED